24.06.2015 Views

vitaminas y minerales

vitaminas y minerales

vitaminas y minerales

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Natural Solutions Foundation<br />

www.HealthFreedomUSA.org ; naturalsolutions@optionline.net<br />

Triglicéridos Séricos: el alcohol y los azúcares simples son de fuentes con bajos niveles de fibra<br />

que pueden elevar los triglicéridos. Por otra parte, este factor de riesgo cardiovascular es muy<br />

sensible a las estrategias alimentarias que incluyen la suplementación con:<br />

• Aceite de pescado 201<br />

• Inositol 202 , 203 , 204<br />

• Té Verde (4 tazas o equivalente) 205<br />

• Colina 206 , 207<br />

• Niacina (vitamina B3) 208 , 209<br />

• Pantetina 210 , 211 , 212<br />

• Cromo 213 , 214 , 215 , 216 , 217<br />

201 Prichard BN, Smith CCT, Ling KLE, Betteridge DJ. Fish oils and cardiovascular disease. BMJ 1995;310:819–20<br />

[editorial/review].<br />

202 Brown WV. Niacin for lipid disorders. Postgrad Med 1995; 98:183–93 [review]<br />

203 Head KA. Inositol hexaniacinate: a safer alternative to niacin. Altern Med Rev 1996;1:176–84 [review]<br />

204 Murray M. Lipid-lowering drugs vs. inositol hexaniacinate. Am J Natural Med 1995;2(8):9–12 [review]<br />

205 Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ<br />

1995;310:693–6.<br />

206 Buchman, Alan L, Ament, Marvin E, Sohel, Mir, Dubin, Mark, Et al, Choline deficiency causes reversible hepatic<br />

abnormalities in patients receiving parenteral nutrition: Proof of a human choline requirement: A placebo-controlled trial,<br />

JPEN, Sep/Oct 2001<br />

207 Watkins SM, Zhu X, Zeisel SH., Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate<br />

liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr. 2003 Nov;133(11):3386-9<br />

208 Berra K. , Clinical update on the use of niacin for the treatment of dyslipidemia. J Am Acad Nurse Pract. 2004<br />

Dec;16(12):526-34.<br />

209 Shepherd J, Betteridge J, Van Gaal L; European Consensus Panel, Nicotinic acid in the management of<br />

dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus<br />

Panel. Curr Med Res Opin. 2005 May;21(5):665-82.<br />

210 Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment with pantethine in patients with<br />

dyslipidemia. Clin Ther 1986;8:537–45.<br />

211 Avogaro P, Bon GB, Fusello M. Effect of pantethine on lipids, lipoproteins and apolipoproteins in man. Curr Ther Res<br />

1983;33:488–93.<br />

212 Maggi GC, Donati C, Criscuoli G. Pantethine: a physiological lipomodulating agent, in the treatment of<br />

hyperlipidemias. Curr Ther Res 1982;32:380–6.<br />

213 Uusitupa MI, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic chromium supplementation on glucose<br />

tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 1983;38:404–10<br />

214 Hermann J, Chung H, Arquitt A, et al. Effects of chromium or copper supplementation on plasma lipids, plasma<br />

glucose and serum insulin in adults over age fifty. J Nutr Elderly 1998;18:27–45.<br />

215 Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes<br />

Care 1994;17:1449–52.<br />

94

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!